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Supplemental Experimental Procedures for the AlphaScreen experiment (Figure 
S3). 
All assays were carried out in 384-well white opaque plates (Whatman, 7701 3100). For 
the experiment in Figure S3B, 2.5 μl of Sas-Fc (40nM) and 2.5 μl of 10D-AP (40 nM) 
were mixed together. To create the binding curves of Figure S3A, the amounts of Sas-
Fc and 10D-AP were systematically varied, with the maximum amount used being 2.5 μl 
of a 100 nM stock (see Figure S3 legend). The mixed proteins were incubated for 4 hr 
at room temperature. 20 μl of a solution containing anti-human IgG coated acceptor 
beads (PerkinElmer alphaLISA kit, AL205C) diluted to 25 μg/ml in alphaLISA 
immunoassay buffer (PerkinElmer, AL000C) containing mouse biotin-labeled anti-AP 
antibody (clone 8B6.18) (Neomarkers, MS-208-B) at 1.65 nM was added, and 
incubation was continued for 1 hr at room temperature. Subsequently, 25 μl of 80 ug/ml 
streptavidin coated donor beads  (PerkinElmer, AL205C), were added at 25 μg/ml in 
AlphaLISA immunoassay buffer, and incubation was continued for another 1 hr. at room 
temperature. The plates were then read on a Synergy 2 (BioTek) multiplate reader at 
570 nm and data were collected using Gen5 2.0 software (BioTek). Owing to the light-
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sensitivity of the beads, all assay steps were performed under subdued lighting, and the 
incubation steps were carried out in the dark. The microplate reader was set up and 
conditions were optimized using AlphaScreen omnibeads, which contain all the 
chemicals necessary to produce a strong AlphaScreen signal without the presence of 
an AlphaScreen Acceptor bead (PerkinElmer, 6760626D).  
The major purpose of the grid experiment of panel A was to find the 
concentrations of proteins at which the binding signal would be maximal. To find this 
maximum, we needed to reach concentrations at which binding in solution outweighs 
binding of the bead-bound proteins to each other. This should cause the signal to 
decrease (the ‘hook effect’), allowing us to define a peak that represents the maximum 
signal. However, the graph shows that we were unable to reach high enough 
concentrations of protein to observe the hook effect, since the signal increased up to the 
maximum concentrations of proteins used. We could not go up to the next concentration 
step in the grid (316 nM of each protein), because when stocks of purified Sas-Fc were 
concentrated to above 120 nM the protein precipitated. As a consequence, we do not 
know at what concentrations the maximal binding signal might be obtained. It was clear, 
however, that Sas-Fc::10D-AP interactions did not generate strong AlphaScreen signals 
at any concentration we were able to attain. We were able to produce 40-fold stronger 
signals, without an increase in background, for lower concentrations of Dscam-AP and 
Dscam-Fc. While the results in (A) and (B) shows that Sas-Fc binds selectively to 10D-
AP, much better signal-to-background ratios were obtained in the modified ELISA 
experiment of Figure 3. Because of this, and because the absolute signal values in the 
AlphaScreen were very low for Sas-Fc::10D-AP relative to Dscam, for reasons we do 
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not fully understand, we used the ELISA to generate the key binding data in the paper, 
with multiple replicates and controls. 
 
 
Supplemental Experimental Procedures for the S2 cell aggregation experiment 
(Figures 3 and S3). 
S2 cells were cotransfected, using Effectene, with 1:20 mixtures of a puromycin 
resistance plasmid (Iwaki et al., 2003) and metallothionein promoter plasmids 
containing either full-length Ptp10D (Fashena and Zinn, 1997) or a fusion of the entire 
XC domain of the large Sas isoform to mCD8-GFP. After 2 days, stably transfected cells 
were selected with 10 µg/ml puromycin and grown out for 3 days. Expression of Ptp10D 
and Sas was induced with CuSO4 (700 µM), and cells were incubated for 4 more days. 
Sodium butyrate (5 mM) was added and cells incubated overnight. Ptp10D and Sas 
cells were then washed and incubated alone or together at ~106 cells/ml in serum-free 
S2 medium overnight (Siebert et al., 2009), followed by fixation and staining with anti-
Ptp10D and anti-Sas. 
 Note that it is not possible to quantitate these cell aggregation results, because 
most cells expressing Ptp10D are not involved in clusters and most Ptp10D cell clusters 
are not associated with Sas cells. Thus, as in the (Siebert et al., 2009) paper on trans 
interactions between Sidestep and Beaten Path, we have simply presented typical data 
as images.  
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 Figure S1 (related to Figure 1). 10D-AP staining of embryos expressing 9 
candidate binding partners using tub-GAL4.  
Staining was performed as in Figure 1. 
(A) tub-GAL4 control. Note that the CNS axon ladder is stained, but there is no staining 
in the periphery. 
(B) tub>CG3722 (E-cadherin/Shotgun). The CNS is brighter than in control, and bright 
staining in the periphery is observed.  
(C) tub>CG31062 (Sidestep). The pattern is similar to (B).  
(D) tub>CG6827 (Neurexin IV). The CNS is bright, but peripheral staining is dim. 
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(E) tub>CG5481 (Robo2/leak). The pattern is similar to (D). Note that the CNS axon 
ladder is altered by Robo2 overexpression. 
(F) tub>CG15020 (a ZP domain protein). The pattern is similar to (C). 
(G) tub>CG5723 (Ten-m). The CNS has a bright granular appearance, and muscle 
attachment sites are prominent.  
(H) tub>CG5810 (an LRR protein). The pattern is similar to (D). 
(I) tub>CG7100 (Cad-N). The muscle fibers are clearly outlined, and CNS axon staining 
is very bright. 
(J) tub>CG1817 (Ptp10D). Note that axons but not cell bodies are stained in the CNS, 
consistent with the restriction of endogenous and overexpressed Ptp10D to axons. The 
muscle fiber outlines are clearly visible. 
Scale bar, 20 µm. 
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Figure S2 (related to Figures 1 and 2). 10D-AP and anti-Sas label the same 
patterns in Sas ectopic expression embryos.  
Embryos were stained either with anti-Sas or 10D-AP (green/white) plus rhodamine-
phalloidin (to visualize muscle fibers; magenta). 10D-AP and anti-Sas cannot be used 
together because anti-Sas is a rabbit antibody and rabbit anti-AP is used as the 
secondary antibody to detect 10D-AP. Each image shows the ventral portion of two 
body wall segments, with anterior to the left and dorsal up. The VNC is at the bottom, 
and one longitudinal tract is visible in each panel. The muscles in the wild-type images 
seem slightly smaller because the embryos were less stretched than the Tub>Sas 
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embryos during dissection. (A, C, E, G) show both signals, while (B, D, F, H) show only 
the anti-Sas or 10D-AP signal, in white.  
(A, B) In wild-type, Sas is expressed on tracheal branches (arrow), but not on muscle 
fibers. Phalloidin labels muscle fibers and a CNS longitudinal axon tract (out of focus). 
(C, D) In wild-type, 10D-AP faintly labels muscle attachment sites (arrow). Staining of 
the longitudinal tract (out of focus) is visible with phalloidin in (C) and with 10D-AP in (D) 
(arrowheads).  
(E, F) In embryos in which the Sas cDNA construct is driven by tub-GAL4 (Tub>Sas), 
anti-Sas brightly labels muscle fibers. The longitudinal tract is brighter than in (A), 
indicating that Sas is expressed at higher levels on axons. 
(G, H) In Tub>Sas embryos, 10D-AP labels muscle fibers. This pattern is almost 
identical to that seen in (E, F). The longitudinal tract is much brighter in (G) and (H) than 
in (C) and (D), reflecting the higher levels of 10D-AP staining on axons. 
Scale bar, 10 µm. 
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Figure S3 (related to Figure 3). Using the AlphaScreen and S2 cell aggregation to 
evaluate binding of Ptp10D to Sas.  
(A) This graph shows the results of a ‘grid’ experiment, in which varying concentrations 
of 10D-AP and Sas-Fc were used for binding. Three sets of half-logarithmic (100.5-fold) 
dilutions were performed, starting from a 100 nM stock of each protein. For the blue 
curve, both proteins were diluted; for the yellow curve, Sas-Fc was held at 100 nM and 
10D-AP was diluted; for the pink curve, 10D-AP was held at 100 nM and Sas-Fc was 
diluted. Each point on the x axis, starting with point 2, for which both proteins are at 100 
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nM, represents a dilution step. For the final step (point 9), one or both proteins were 
brought to zero concentration. The y axis is absorbance at 570 nm. The three binding 
curves all have similar shapes. This experiment shows that Sas-Fc and 10D-AP exhibit 
concentration-dependent binding to each other (see Supplementary Experimental 
Procedures for further information).  
(B) An example AlphaScreen experiment in which Sas-Fc and 10D-AP were each used 
at 40 nM. The Sas-Fc::10D-AP signal is set at 100%. In this experiment, as well as in 
the grid experiment of (A), the signal-to-background ratio is 5- to 6-fold.  
 (C-E) High magnification views of portions of clusters, showing apposition of Sas and 
Ptp10D cells.  
(C, C’, C”) A single Sas cell extends processes that intercalate between Ptp10D cells. 
(D, D’, D”) Two Sas cells, which may have recently divided, are apposed to three 
Ptp10D cells. 
(E, E’, E”) Two bright Sas cells within a cluster of Ptp10D cells. Note the straight 
borders of the interfaces between the right-hand Sas cell and the Ptp10D cells, which 
are suggestive of adhesion. 
Scale bar, 10 µm. 
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Figure S4 (related to Figure 4). Expression of Sas on CNS glia.  
(A) This is a merge of the images in Figures 4A and B, showing the superimposition of 
Sas (magenta) and Ptp10D (green) expression. A longitudinal tract is indicated (arrow), 
as are the intersegmental and segmental nerve roots (arrowheads). 
(B, B’,B”) Visualization of Repo-expressing CNS glia in Repo>mCD8-GFP embryos by 
double-staining with anti-GFP (green/white) and anti-Sas (magenta/white). Note that the 
longitudinal (interface) glia along the longitudinal tracts (dotted outline) express both 
GFP and Sas. The channel glia, which are dorsally located at the midline (arrows), do 
not express Sas, or express it at much lower levels.  
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(C, C’, D, D’) These two CNS images, from two different late stage 16 embryos, show 
anti-Sas (magenta/white) and 1D4 (green/white) staining. The focal planes are very 
dorsal, so that the 1D4 longitudinal bundles are completely out of focus. The dorsal 
median (DM) cells (arrow), which are on the dorsal surface of the CNS and express Sas 
at high levels, serve as points of reference. 
(C, C’) The focal plane is at the level of the DM cells. In this focal plane, a web of Sas-
expressing apical cell surfaces is observed (dotted outline). These are likely to be 
perineurial and subperineurial glia, which enwrap the cell bodies of the CNS. Perineurial 
glia do not express Repo. 
(D, D’) The focal plane is slightly ventral to the DM cells, which are now out of focus. 
Sas-expressing cells are observed on top of and lateral to the longitudinal tracts (dotted 
outline). These are likely to be interface glia. 
Scale bar, 10 µm. 
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Figure S5 (related to Figure 6). Ptp10D Ptp69D and sas Ptp69D phenotypes for 
Apterous (Ap) and Connectin neurons, and rescue of sas Ptp69D phenotype by 
glial expression of Sas.  
 (A-C) Confocal z-stacks of the dorsal region of the VNC, showing one Ap cell body per 
hemisegment and the longitudinal bundles formed by the Ap axons (arrowhead in (A)). 
Note that there are several other Ap cell bodies ventral to these cells that also 
contribute axons to these bundles; these are not visible in these z-stacks.  
(A) The normal pattern of Ap cell bodies (arrow) and axons in late stage 16 embryos 
visualized by driving mCD8-GFP with Ap-GAL4. Scale bar, 10 µm. 
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(B, C) In most Ptp10D Ptp69D and sas Ptp69D embryo segments, there are no Ap 
axons. Only the cell bodies are visible, and they express GFP at reduced levels.  
(B’, C’) When Ap axons are observed, they are truncated and extend posteriorly rather 
than anteriorly (arrows).   
(D) In wild-type late stage 16 embryos, anti-Connectin strongly stains two axon bundles 
(arrowheads) in each longitudinal tract and a commissural bundle (double arrowhead). 
The longitudinal bundles are ventral to the 1D4 bundles. There is additional weaker 
staining on many other cell bodies and axons.  
(E) In Ptp10D Ptp69D, the inner bundle is present (arrowhead), although it has some 
gaps, but the outer longitudinal bundle is usually missing (bracket). In this genotype, 
abdominal segments have weaker Connectin staining than thoracic segments (top 
segment is T3).  
(F) A similar phenotype is observed in sas Ptp69D, but abdominal segments stain as 
strongly as thoracic segments.  
(G) A sas Ptp69D/Df, UAS-Sas embryo stained with 1D4. Two segments with ectopic 
midline crossing are indicated. 
(H) A sas Ptp69D/Df, Gcm-GAL4, UAS-Sas embryo. All three longitudinal tracts are 
present and unbroken, and there are no ectopic midline crossing events. 
(I) An embryo overexpressing Sas from the Ap-GAL4 driver, stained with anti-Sas. In 
this image, the Ap cell bodies (see panel (A) for the mCD8-GFP pattern conferred by 
this driver) are below the plane of focus. Note that although Sas is overexpressed only 
by these few cell bodies, anti-Sas reactivity spreads out within a plane dorsal to these 
cell bodies, presumably in the ECM. The yellow bracket indicates the Sas pattern 
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associated with Sas overexpression by a single Ap neuron cluster. If all Sas was 
transmembrane and associated with Ap neuron cell surfaces, one would expect to see a 
pattern like that in (A). Endogenous Sas is present in this embryo, but is at much lower 
levels, so is not seen at this exposure.  
(J) Bar graph of ectopic midline crossing phenotype. The presence of the UAS-Sas 
cDNA element reduces the frequency of ectopic midline crossing, suggesting that there 
is leaky expression from this element in the absence of a driver. When Gcm-GAL4 is 
also present, there is almost no ectopic midline crossing (3%). 
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Figure S6 (related to Figure 7). Ectopic midline crossing caused by Sas 
overexpression in neurons and midline glia, in wild-type and Ptp10D- 
backgrounds.   
(A) The CNS has a normal structure when Sas is expressed from the Elav-GAL4 or 
Sim-GAL4 drivers, but occasional midline crossing of the inner 1D4 bundle is observed. 
This bar graph shows that the percentage of ectopic midline crossing is not changed 
when Ptp10D is genetically removed from Elav>Sas embryos, but is doubled when 
Ptp10D is removed from Sim>Sas embryos. Coexpression of Ptp10D and Sas in 
Ptp10D embryos bearing the Repo-GAL4 driver completely rescues the ectopic midline 
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crossing phenotype (compare to Figure 7E). The number of segments analyzed is 
indicated.  
(B-H) Representative images (whole-mount embryos) of 1D4 staining of the genotypes 
shown in (A).  
Scale bar, 10 µm. 
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Table S1. 
 
CG # Gene name Line # 
CG7749 fat2   GE20158 
CG17941 dachsous GE16163 
CG11895 fmi/stan GS9046 
CG10239 Cad96Ca GE24017 
CG4655  GE22560 
CG6445    GE22619 
CG6977    GE20793 
CG31009 Cad99c d04999  
CG31774 friend of echinoid GE13572 
CG3624    GS7500 
CG4135 beaten path-IIb EY07690  
CG4814     EY01251 
CG32600 dpr8 GE1992 
CG5597  GE18518 
CG7607  EP3313 
CG7644 beaten path-Ib GS12659 
CG10946  dpr14 GS7441 
CG31369   GS12277 
GE21731 
CG31708   GS10376 
GE15186 
CG31431  GE22558 
CG33141 sticks and stones  EY08142 
CG31646   GE15020 
CG14372   EY08788 
CG14469  dpr12 f07539 
CG31361 dpr17 f07135 
CG15009 ImpL2 d11062 
CG15312  GS7364 
CG15630  GE14234 
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CG12191  dpr20 GS12770 
GE17036 
CG8779 Neuromusculin GS9446 
CG6669 Klingon   GS10439 
CG8964   EY03841 
CG13506  GE16794 
CG14521   EY02750 
CG32311 zormin  d08887 
CG17716 faint sausage  GS10625 
CG7223 heartless d07110 
CG8222 Pvr f05484 
CG8967 off-track   d01360 
CG5227 sidekick   EP369 
CG5481 robo2 EP2582 
CG6490  GE21193 
CG9211 iHog GE16164 
CG31190  f00600  
CG14964   GS11359 
CG15427 turtle  GS9718 
CG17800 Dscam d01097 
CG17839  GS11043 
CG31738  CG31738  GE13451 
CG6173 Kallmann   d01966 
f00379 
CG18630   f07661 
CG32796 boi GE4127 
CG14226 domeless  d09436 
CG6899 Ptp4E  EP425 
CG1817 Ptp10D  EP1172 
CG2005 PTP99A   EY07423 
CG18085 sevenless   GS8057 
GE3589 
CG10236 Laminin A  GS10699 
EP3678 
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CG15288 Laminin A1,2 
wing blister 
GS7312 
GE14893 
CG7123 Laminin B1   GS9163 
GS11222 
EP2178 
CG3322 Laminin B2   f01875 
CG7981 trol  GE10067 
CG3619 Delta   GS3299 
CG10521 Netrin B   GS1029 
CG8355 Slit   EY10695 
CG2991  GE13774 
CG3135 shifted GE946 
CG4090   GE13141 
CG4250  GE17627 
CG5723 ten-m   GS9267 
EY03921 
CG5639   f05052 
CG8403 SP2353 d01706 
CG32179 spitz2(Keren)  GS3237 
CG6827 Neurexin IV   EP809 
EP604 
CG14307 fruitless   GS3153 
CG7447   EY07651 
CG7565  GS9380 
GE25495 
EY04273 
CG10334 spitz d03659 
CG10491 vein GS12044 
CG11101 pawn  GE10541 
CG11326 Thrombospondin  GE10734 
CG11377   EY09172 
CG17610 gurken  d10614 
CG32356 ImpE1  GS10647 
GS11510 
GE23751 
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CG12781 nahoda  GE16167 
EP627 
CG12086 cueball    EY01263 
CG5912 arrow EY04453 
CG8909  GE5012 
CG1372 yolkless   GE5203 
CG12139  GE3293 
CG33087  GS12223 
GE16005 
CG5634 distracted GS11284 
EY05482 
EP3400 
CG32092  GE29338 
EY11189 
f02558 
CG6863 Tolkin   GS69 
CG32699  GS1129 
EP0352 
CG7179   GS13316 
GS20243 
CG32635  GE2396 
CG3095    f06503 
CG3413 windpipe GE13015 
CG3408    GS10831 
CG4054    GE10226 
CG5096    GS2165 
CG5195  GS20382 
CG5407 SUR-8   GS3141 
CG5528 Toll-9 GS51 
CG5810    f01959 
CG5820 gp150   GS66 
EY08250 
CG5851 sds22 f01874 
CG6590    EY07744 
CG6860    GE15908 
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CG6959  GE22610 
CG7250 Toll-6 GE26496 
CG7702   EY00368 
CG8595 Toll-7 GE15025 
CG8561 Acid labile subunit GS10548 
GE12785 
CG8896 18-wheeler   GS13286 
GE14005 
CG9031    GS11003 
CG9044    GS10919 
CG10255 Lap1 GE10296 
CG11280 tartan   GS10885 
CG11282 capricious   GS10839 
CG13125    GS11753 
CG31137 twin EY02330 
CG31635    GS10303 
CG14185    GE24319 
CG14351  EY11244 
CG14662    GE21218 
CG14995    GS3174 
CG15151 Pray for elves GS11387 
CG1504    GE4771 
CG5784 Mapmodulin EY01282 
CG17335 Small bristles GE4725 
CG32687    GE2673 
CG12002 peroxidasin   GS9354 
CG12199 kekkon-like   GE3339 
CG4192 kekkon 3   GS12192 
CG12283 kekkon 1   GS7501 
EP655 
CG9431 kekkon-4  GS10427 
CG16974    EY01543 
CG1804  GE28037 
CG4096    GE5158 
CG10145 M-Spondin   GS12735 
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CG10663    GS7321 
GE28907 
CG17739  EY18336 
CG31619    GS10109 
CG7147 kuzbanian   GS11029 
CG5661 Sema-5c GS12797 
CG18405 Sema-1a GS2268 
CG9095  GS8168 
CG9138 SP1070  GS11655 
CG1500 Furrowed  GS7008 
CG2040 hig   GS10464 
EY03336 
CG32146 dally-like   GS10784 
CG2264 testican homolog   GE11359 
EY00918 
CG3599 vanin homolog   GE2207 
CG15671 crossveinless 2 EP1103 
CG15828  G7994 
CG14162 Dpr-6 f07173 
CG31814  GS 10783 
CG32791  GE2966 
CG5803 Fasciclin 3 d05288 
CG10972 ppk12 EY13952 
CG31605 Bsg GS11859 
EY10523 
CG15138 Beat-IIIc GS9617 
CG10152 Beat-IV EP3281 
CG8434 lambik GS17119 
CG3903 gliotactin GE13413 
CG13349  GE14555 
CG6789  GE5916 
CG7052 Tep2 G3592 
CG7068 Tep3 G2778 
CG7586 Mcr G3618 
CG13079  GS11623 
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CG8084  GS9498 
CG8827 Ance G3223 
CG10142 Ance-5 G3082 
CG7013  G15626 
CG4531 argos GS12984 
d00253 
CG6588 fasciclin I d07727 
CG3359 midline fasciclin G3944 
CG5758  GS22939 
CG4280 croquemort G3220 
CG1887  f07156  
CG2736  f02107 
CG7000  GS10889 
CG7228 peste G3611 
CG10345  f07636 
CG4835  GS14786 
CG5756  f07526 
CG14796  G17286 
CG2989  GE555 
CG8756  GE17285 
CG32209  d03931 
CG17905  GE14153 
CG32499  GE11981 
CG4778  GE11195 
CG10287 gasp d02290 
CG13312   GE29326 
CG11372 Galectin GS13007 
d09394 
CG11374  GS11190 
CG14879  G5507 
CG32226  G4525 
CG6895 GNBP1 G5241 
CG5008 GNBP3 GS12348 
CG6822  EP3212 
CG6014  G15936 
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CG15765  G17073 
CG9488 Discoidin domain 
receptor 
f08070 
d06926 
CG6217  GS13403 
CG12492  G13871 
CG8399  G13327 
CG32922  GS21977 
CG7352  G4576 
CG12004  GS16151 
EY09136 
CG5850  GS21004 
CG13492  GS17711 
CG10650  GS21331 
CG7851  GS17574 
CG33038   GE11809 
CG15110 brother of tout-velu  GE15507 
CG13194 pyramus GS22603 
CG12443 thisbe G19748 
CG8642  GS13795 
CG17579 scabrous GS9930 
CG2507 stranded at second GE24911 
CG30418 nord GS11012 
CG9559  Fog f06104 
f05336 
CG18734 Fur2 GE1121 
CG10772 Fur1 EP3499 
CG17697 fz d04176 
d04570 
CG16785 fz3 GE1592 
CG4626 fz4 GE31942 
CG1106  GS10156 
CG6575 gliolectin EP3449 
CG4934 brainiac G68 
CG8668  G2829 
CG11357  G9588 
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CG3038  G728;-36 
CG8673  EY15808 
CG13904  GS11028 
CG8734  GS6135 
CG9520  G18317 
CG10580 fringe G5151 
CG9659 egghead G669 
CG32540 CCKLR-17D3 GS22193 
CG13702 allatostatin C 
receptor 2  
d08685 
CG33344 CcapR f01987 
CG10483   GE22810 
CG10823   GS11212 
CG12290   EY05347 
CG12370   GE10659 
CG13758   EY11851 
CG13995   GS10590 
EP2273 
CG18314   d05515 
CG2061  EP1537 
CG2901   GE3026 
CG30106  f06893 
f06894 
CG32843  f06589 
CG4313  GE3444 
CG4322  GE144 
CG6919  f02819 
CG6986   d00672 
CG7431  d00913 
CG7497  GE20576 
CG8795  f02573 
CG9643   EY07345 
f02198 
CG8639 Cirl GE12466 
CG9569 DD2R f06521 
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CG5911 ETHR GE28632 
CG6936 methuselah  d05374 
CG17061 methuselah-like 10  GS21073 
CG17795 methuselah-like 2  GS20687 
CG6530 methuselah-like 3 GE15782 
CG7476 methuselah-like 7  GS21256 
CG8095 scab, volado EP2591 
CG5372  GS12413 
CG1762 beta neu integrin GE16247 
CG32659 Tenascin 
accessory  
GE1914 
CG7466  GE10936 
CG1077  GE27843 
CG5392  EY01996 
CG32354  GE24651 
CG33466 follistatin GE16028 
CG31092 LpR2 GE24420 
CG12497  GE5356 
CG6739  d09967 
CG1632  GE2039 
CG32432  GE21767 
CG4604  Glial Lazarillo GE14060 
CG9342  G3187 
d07488 
CG1399  GS9001 
CG8197  G7845 
CG4168  f06058 
CG12214  GE23737 
CG14485 swi2 EY03082 
CG17667  EY09216 
CG2247  GE8222 
CG7665 Fsh-Tsh-like 
receptor 
GS16857 
CG10702  GE17408 
CG3837  GE22018 
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CG32464 l(3)82Fd GS16948 
CG1794  GS6122 
CG9655 nessy GS14209 
CG9526  EY06644 
CG17937  midway EY07280 
CG11495  rasp GE21385 
CG1221  G5226 
CG18321  GE30385 
CG11937 amnesiac EP1571 
EP346 
CG13633 Allatostatin GE25324 
CG18090 Drosulfakinin GE26995 
CG2346 FMRFamide-
related 
GS20864 
CG13480 Leucokinin f06006 
CG3441 Neuropeptide-like 
precursor 1 
GE16505 
CG13061 Neuropeptide-like 
precursor 3 
GS10896 
CG13968 short neuropeptide 
F precursor 
GE14853 
CG7291 Niemann-Pick C2 GE12107 
CG10183  EY02921 
CG14204  G17581 
EY05761 
CG11353  G4385 
CG14205   G17121 
CG13325  G19628 
CG14219  G1281 
CG32645  G488 
CG5993  G17133 
CG34378 Pvf3 f04177 
CG13101  GS16273 
EY01250 
EP2168 
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CG9552 rolling stone EP2569 
CG9555  GE14634 
EY5571 
CG4480  GS11125 
CG12070 Saposin-related d00213 
d00389 
CG3376  XP d05970  
CG15533   GS16402 
CG10284  G4097 
CG9540  GS22570 
CG32679  G463 
CG17210  GS16981 
CG30486  GS13562 
CG11977  GS13530 
CG3921  GE10632 
CG10221  GS11870 
CG4316  G8915 
CG2105  GE13145 
CG3074   GS10363 
CG6134 spaetzle d02405 
CG13313  GS21998 
CG13499  d11680 
d00934 
CG14760  GE12448 
CG15153  GE10882 
CG14280  GE20853 
CG17264  EY07056 
CG30371  GS14738 
CG8075 Van Gogh f04290 
CG9614 pipe G4081 
CG10234 Hs2ST GS6068 
CG9550  GS18034 
CG7890  G608 
CG33147  EY11923 
CG32373  GS14433 
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CG9093 Tsp26A GE12891 
CG8666 Tsp39D d01894 
CG14468 Tsp42A GE14991 
CG18817 Tsp42Ea EP2210 
CG12846 Tsp42Ed GE12729 
CG10106 Tsp42Ee f06294 
CG12845 Tsp42Ef GS16897 
EP2608 
CG12143 Tsp42Ej GE13532 
CG12840 Tsp42El GE11349 
EY08356 
CG12839 Tsp42En GS12672 
CG12837 Tsp42Er GS14758 
CG4690 Tsp5D GE4237 
CG4999 Tsp66E GE30517 
CG5492 Tsp74F GE22775 
CG4591 Tsp86D GS12387 
CG6120 Tsp96F GE28078 
CG16987 dawdle, Alp23B G3085 
CG5562 gbb GS12725 
CG8224 baboon GS21092 
CG7904 punt GS22331 
CG8647  GE27366 
CG12410 crossveinless G17312 
CG11582  GS11766 
CG18402 insulin-like receptor  f03155 
CG4007 Nrk GS8003 
CG17559 dnt GE10367 
CG3915  drl2 f00086 
CG31127 Wsck GS16114 
CG7103  G818 
CG13780  G18227 
CG3125  G282 
CG13252  G5112 
CG32647  d05563 
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CG1916 Wnt 2 d03132 
f00794 
CG8804 wunen GE20037 
CG8805 wunen2 GS10006 
EP2527 
CG11437  GE24251 
CG11438  GS14810 
CG12746  EY10535 
CG13432  G11849 
CG9355 dusky G17259 
CG15013 dusky-like GS20894 
CG15020  G19813 
CG2467  G1385 
CG10005  G4867 
CG9369 miniature EP0406 
CG5847  G8605 
CG1499  GE21553 
CG7802  d07781 
CG17111  f00307 
CG17131 SP71 GE50193 
 
This table lists the 311 genes screened in this paper and the corresponding insertion 
numbers. Additional information on all of these genes, including domain types and 
insertion positions, is included in Supplementary Table 1 of (Kurusu et al., 2008). For 
the screen in this paper, we removed genes from the Kurusu et al. list that seemed 
unlikely to encode ligands or coreceptors for CAM-like cell surface proteins. These 
included GPCRs, tetraspanins, neuropeptides, and others.  
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